| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $122.9M | $160.3M | $131.2M |
| YoY Revenue Growth % | -23.3% | +22.2% | — |
| Gross Profit | $51.7M | $64.4M | — |
| Gross Margin % | 42.1% | 40.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$11.0M | -$2.9M | -$6.7M |
| Operating Margin % | -8.9% | -1.8% | -5.1% |
| Net Income (GAAP) | -$11.4M | -$4.5M | -$9.0M |
| EBITDA (Normalized) | -$10.6M | -$1.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.3M | $18.6M | $237.0K |
| Capital Expenditures (CapEx) | $505.0K | $1.5M | — |
| Free Cash Flow (FCF) | $6.8M | $17.1M | $237.0K |
| FCF Margin % | 5.5% | 10.7% | 0.2% |
| Return on Invested Capital (ROIC %) | -14.2% | -3.2% | — |
| Cash & Short-Term Equivalents | $23.0M | $19.2M | — |
| Total Debt (Short + Long Term) | $9.7M | $11.6M | — |
| Total Stockholders' Equity | $74.4M | $77.9M | — |